Dr. Suresh Chintalapati is a visionary leader and pioneer in biotechnology, serving as the CEO and Chairman of Mabgenex since founding the company in 2018. He also served as the President and Chief Business Officer of Triangulum Biopharma (2016-25) a preclinical rodent research services company he founded in 2016, and a member of the International Advisory Board at Woxsen University. With 15 years of research experience in molecular biology and immunology, he has published over a dozen peer-reviewed papers and conducted postdoctoral research at Sanford Burnham Prebys Medical Discovery Institute. Previously, he held strategic roles in molecular diagnostics, business development, and commercialization at organizations like Illumina, Pathway Genomics, and GenomeSense. Dr. Chintalapati holds an MS in Biotechnology from the University of Hyderabad, a PhD in Molecular Biology from CCMB, and an MBA, driven by a passion for advancing science and technology for humanity's benefit.

Dr. Khandrika is a creative problem-solver with over 22 years of experience in cell and molecular biology, specializing in oncology research. He holds a PhD in Molecular Biology and has completed postdoctoral research at the University of Colorado Denver and IOSI in Switzerland. As both a lead researcher and team player, he has authored several peer-reviewed publications. Beyond his dedication to healthcare, Dr. Khandrika is passionate about environmental causes and agricultural innovations.

Dr. Satyamurthy Kundharapu is a Senior Scientist at mAbGenEx, leading research in antibody engineering and the development of protein therapeutics while overseeing key platform advancements. With over 12 years of experience in protein chemistry and structural biology, his work has provided critical insights into the structure-function relationships of Dengue virus nonstructural proteins, advancing antiviral therapy design. At CCMB Hyderabad, he spearheaded efforts in protein therapeutics using directed evolution approaches. Dr. Kundharapu holds a PhD in Structural Virology from NISER Bhubaneswar and MSc and BSc degrees in Biotechnology from Osmania University, Hyderabad. His research not only enhances understanding of protein interactions and dynamics but also translates into therapeutic innovations aimed at transforming disease treatment, reflecting his vision to positively impact patients' lives through scientific discovery.

Dr. Aswani Valiveti advises Mabgenex on innovation positioning and strategic partnerships, leveraging his extensive experience in life science research, strategy consulting, innovation management, and early-stage enterprise formation. As the Founder and Principal Consultant at Suchanum Consulting LLC, he helps clients advance early-stage discoveries to market, with prior clients including the NIH Office of Technology Transfer, venture investors, and multiple startups. Dr. Valiveti holds a PhD in Molecular and Cell Biology, an MBA, and an MS in Business & Management from the University of Maryland, College Park, as well as an MSc in Biochemistry from the University of Hyderabad.

Dr. Sadanand Vodala is a renowned scientist in Translational Medicine, specializing in hematology, solid tumor oncology, and biomarker discovery. He currently serves as Clinical Development Lead at BI and has over two decades of research experience, including leadership roles at NantOmics (Associate Director, Translational Sciences), Liquid Genomics (Vice President, Global Scientific Affairs), and Arid Pharmaceuticals. Dr. Vodala completed his postdoctoral training at the Howard Hughes Medical Institute under Nobel Laureate Prof. Michael Rosbash, earned his PhD from the University of Melbourne, Australia, and holds a Master's degree from the University of Hyderabad, India.

Ravi Kiran Bhaskar (RKB) is a software professional with over 20 years of experience, specializing in Natural Language Processing, Machine Learning, Artificial Intelligence, and High-Performance Computing. His contributions to medicine and biotechnology include developing AI-driven strategies and applications for hospitals, healthcare services, and clinicians. RKB successfully created an ML model to reliably detect hypertension in collaboration with the University of Glasgow and led a multidisciplinary team for the COVID-19 Open Research Dataset Challenge (CORD-19), organized by AI2, CZI, MSR, Georgetown, NIH, and The White House. He holds an MS in Electrical Engineering from George Mason University, USA, and a BE in Electronic Engineering from Nagpur University, India.